Proscia
PrivateLast Round
VC Round
Mar 19, 2025
Total Funding Raised
$96.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Proscia operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a VC Round in March 2025.
Proscia is a health care technology company that provides an AI-powered digital pathology platform designed to accelerate cancer research and improve diagnostic workflows.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proscia Comparables
Compare Proscia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indica Labs | 90% | |
| Techcyte, Inc. | 88% | |
| Tempus | 85% |
For institutional investors. Book with your work email.
Proscia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 19, 2025 | ||||
| Series C Extension | Mar 14, 2024 | ||||
| Series C | Dec 29, 2023 | ||||
| Series C | Jun 14, 2022 | ||||
| Series B | Dec 1, 2020 | ||||
Series A | Sep 26, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proscia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| avenuealtd.com | VC Round |
| Flybridge | Series A |
| TCP Venture Capital | Seed |
| Emerald Development Managers | Series C, VC Round, Series A, Seed |
| Fusion Fund | VC Round, Series A |
| Triangle Peak Partners | Series C, Series C Extension, VC Round |
| HV Fund | Series B, Series C, Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 45% MoM.
- Jan 1, 2026
Named "Best in KLAS for Digital Pathology in Europe" and top performer in the U.S.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- adopts_technologyOct 21, 2026
On Oct 21st '26, Proscia Inc. uses Amazon S3 and the Altinity Kubernetes Operator to build unlimited observability.
- recognized_asAug 11, 2026
Proscia Inc. earns the top score for supporting customers' integration goals in KLAS Research's Digital Pathology 2026 report on the United States market, based on customer feedback, and receives the report's highest overall performance score.
- has_revenueAug 10, 2026
Proscia Inc. reaches $16.4M in revenue in 2025.
For institutional investors. Book with your work email.
Proscia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proscia's valuation, stock price, and market status.
Is Proscia a public or private company?
Proscia is a private company.
What is the current stock price of Proscia?
Proscia is a private company, so its shares have no public market price. Caplight tracks Proscia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proscia worth (valuation)?
Valuation information for Proscia is not publicly available.
Can I buy Proscia stock?
Proscia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proscia's last funding round?
Proscia's most recent funding round was VC Round on March 19, 2025.
Who are the main investors in Proscia?
Key investors in Proscia include Flybridge, Emerald Development Managers, Triangle Peak Partners, Scale Venture Partners, Alpha Intelligence Capital.
Will Proscia IPO soon?
No public IPO plans have been announced for Proscia.
How can I track Proscia secondary market activity?
Caplight tracks bids, offers, and trades in Proscia's shares on secondary markets.